After recalling the various therapeutic aids proposed for the treatment of hydatid disease, personal experience in the use of mebendazole in patients suffering from pulmonary hydatidosis is reported. On the basis of the results obtained, it is concluded that mebendazole represents a useful therapeutic approach provided it is administered in full doses and for a long period in well selected cases, namely patients with cysts of limited dimension and, probably, of comparatively recent onset.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Stability of Ternary Drug-Drug-Drug Coamorphous Systems Obtained Through Mechanochemistry.
Pharmaceutics
January 2025
Department of Chemical and Pharmaceutical Sciences, University of Trieste, Piazzale Europa 1, 34127 Trieste, Italy.
This study investigates the preparation of coamorphous systems composed entirely of active pharmaceutical ingredients (APIs), namely praziquantel, niclosamide, and mebendazole. The objective was to formulate and characterize binary and ternary coamorphous systems to evaluate their structural, thermal, and stability properties. Ten different mixtures (binary and ternary) were designed through a mixture design approach and prepared using a sustainable, one-step neat grinding process in a lab-scale vibrational mill.
View Article and Find Full Text PDFMebendazole Exerts Anticancer Activity in Ovarian Cancer Cell Lines via Novel Girdin-Mediated AKT/IKKα/β/NF-κB Signaling Axis.
Cells
January 2025
Infectious Diseases & Immunology Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology, Jadavpur, Kolkata 700032, India.
Mebendazole (MBZ), a benzimidazole anthelmintic and cytoskeleton-disrupting compound, exhibits antitumor properties; however, its action on ovarian cancer (OC) is not clearly understood. This study evaluates the effect of MBZ on OC cell lines OVCAR3 and OAW42, focusing on cell proliferation, migration, invasion, and cancer stemness. The underlying mechanisms, including cytoskeletal disruption, epithelial-mesenchymal transition (EMT), and signaling pathways, were explored.
View Article and Find Full Text PDFRare Presentation of Echinococcal Disease: A Systematic Review on Arterial Hydatid Cyst.
Ann Vasc Surg
December 2024
Unit of Vascular Surgery, Department of Cardiovascular and Pulmonary Sciences - Università Cattolica del Sacro Cuore, Rome, Italy; Unit of Vascular Surgery, Department of Cardiovascular Sciences - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Article Synopsis
- Echinococcosis is a rare but serious parasitic disease primarily affecting the liver and lungs, with arterial echinococcosis posing significant health risks, yet its management and outcomes are not well-documented.
- Researchers conducted a thorough review of literature and identified 32 cases, revealing that most patients experience chronic pain, with the majority requiring surgical removal of cysts and antiparasitic treatment, predominantly using albendazole.
- While most patients had good outcomes post-surgery, the condition remains dangerous, highlighting the need for further investigation into effective treatment strategies and patient management.
Synergistic inhibition of proliferation and induction of apoptosis in oral tongue squamous cell carcinoma by mebendazole and paclitaxel via PI3K/AKT pathway mitigation.
Naunyn Schmiedebergs Arch Pharmacol
November 2024
Department of Postgraduate Training Base of Chifeng College of Jinzhou Medical University, Chifeng City, 024000, Inner Mongolia, China.
Article Synopsis
- Oral tongue squamous cell carcinoma (OTSCC) is a common and serious cancer affecting oral health, prompting a study on the effects of mebendazole (MBZ) and paclitaxel on its growth and underlying mechanisms.
- The research found that both MBZ and paclitaxel significantly inhibited cell growth and increased apoptosis rates in cancer cells, particularly when used in combination.
- The combination treatment not only impacted key signaling pathways related to cell survival (PI3K/AKT) but also reduced microtubule formation, indicating potential for these drugs as effective treatments for OTSCC.
Current status of drug therapy for alveolar echinococcosis.
World J Hepatol
November 2024
Department of Hepatobiliary and Pancreatic Surgery, Qinghai Province Research Key Laboratory for Echinococcosis, Affiliated Hospital of Qinghai University, Xining 810001, Qinghai Province, China.
Article Synopsis
- * Current treatment primarily involves surgery or lifelong use of anti-AE medications like albendazole and mebendazole, which can manage the disease but are not curative and may cause harmful side effects.
- * New potential therapies are being explored, including synthetic and natural compounds, which aim to improve effectiveness and reduce side effects by targeting the parasitic metabolism and structure, with ongoing research to refine these treatment options.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!